A detailed history of Good Life Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Good Life Advisors, LLC holds 28,655 shares of NVO stock, worth $2.5 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
28,655
Previous 26,362 8.7%
Holding current value
$2.5 Million
Previous $3.76 Million 9.33%
% of portfolio
0.22%
Previous 0.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$119.07 - $145.42 $273,027 - $333,448
2,293 Added 8.7%
28,655 $3.41 Million
Q2 2024

Jul 17, 2024

BUY
$122.71 - $146.91 $293,890 - $351,849
2,395 Added 9.99%
26,362 $3.76 Million
Q1 2024

May 02, 2024

BUY
$102.11 - $135.92 $152,348 - $202,792
1,492 Added 6.64%
23,967 $3.08 Million
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $1.97 Million - $2.37 Million
22,475 New
22,475 $2.33 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Good Life Advisors, LLC Portfolio

Follow Good Life Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Good Life Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Good Life Advisors, LLC with notifications on news.